PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Sigmund Freud University, Medical School, Vienna, Austria. Electronic address: louisa.hempel@gmail.com.\', \'Cancer Center Dachau, Germany.\', \'Fraunhofer Institute of Optronics, System Technologies, and Image Exploitation IOSB, Karlsruhe, Germany.\', \'MVZ Laboratory Freising, Germany.\', \'Oncological Center Fürstenfeldbruck, Germany.\', \'Oncological Center Dachau, Germany.\', \'Oncological Center Neusäß, Germany.\', \'BioVariance GmbH, Germany.\', \'Oncological Center Donauwörth, Germany.\', \'III. Medical Department, Technische Universität München, Munich, Germany.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S0093-7754(20)30124-X10.1053/j.seminoncol.2020.12.003
?:hasPublicationType
?:journal
  • Seminars in oncology
is ?:pmid of
?:pmid
?:pmid
  • 33500147
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.099
?:rankingScore_hIndex
  • 121
is ?:relation_isRelatedTo_publication of
?:title
  • Rare SARS-CoV-2 antibody development in cancer patients.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33500147>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33500147>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all